Any feedback?
Literature summary for 5.3.99.2 extracted from
- Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage? (2009), Ther. Drug Monit., 31, 126-130.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | in patients receiving long-term intravenous administration of gentamicin for the treatment of infective endocarditis, systemic clearance of gentamicin is reduced by 10% from the early to late treatment phase, wherease urinary lipocalin-type prostaglandin synthase excretion shows a significant increase. No significant changes are observed for urinary beta2-microglobulin and N-acetyl-beta-D-glucosaminidase concentrations | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
isoform liocalin-type prostaglandin D-synthase | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
